World's Best Scientists 2026 revealed!

D-Index & Metrics

Economics and Finance

D-Index
40
Citations
5957
World Ranking
2316
National Ranking
69

Best Publications

  • Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis

    M. Westwood;M. Joore;J.P.C. Grutters;K. Redekop

  • How costly is particle therapy? Cost analysis of external beam radiotherapy with carbon-ions, protons and photons

    Andrea Peeters;Janneke P.C. Grutters;Madelon Pijls-Johannesma;Stefan Reimoser

  • High-sensitivity troponin assays for the early rule-out or diagnosis of acute myocardial infarction in people with acute chest pain: a systematic review and cost-effectiveness analysis

    Marie Westwood;Thea van Asselt;Bram Ramaekers;Penny F Whiting

  • GRADE Guidelines 30: the GRADE approach to assessing the certainty of modeled evidence-An overview in the context of health decision-making.

    Jan L Brozek;Carlos Canelo-Aybar;Elie A Akl;James M Bowen

  • Current and future medical costs of asthma and chronic obstructive pulmonary disease in The Netherlands.

    M P Rutten-van Mölken;Maarten Postma;M A Joore;M L Van Genugten

  • Epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation testing in adults with locally advanced or metastatic non-small cell lung cancer: a systematic review and cost-effectiveness analysis

    Marie Westwood;Manuela Joore;Penny F Whiting;Thea van Asselt

  • Tinnitus: a cost study.

    Iris H. L. Maes;Rilana F. F. Cima;Johannes W. Vlaeyen;Lucien J. C. Anteunis

  • Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.

    Marie Westwood;Bram Ramaekers;Penny Whiting;Florian Tomini

  • Risk scores to guide referral decisions for people with suspected ovarian cancer in secondary care: a systematic review and cost-effectiveness analysis.

    Marie Westwood;Bram Ramaekers;Shona Lang;Sabine Grimm

  • Joint recovery programme versus usual care: an economic evaluation of a clinical pathway for joint replacement surgery.

    Daniëlle E Brunenberg;Mike J van Steyn;Judith C Sluimer;Linda L Bekebrede

  • Choosing between measures: comparison of EQ-5D, HUI2 and HUI3 in persons with hearing complaints

    Janneke P. C. Grutters;Manuela A. Joore;Frans van der Horst;Hans Verschuure

  • Cost-effectiveness of the 70-gene signature versus St. Gallen guidelines and Adjuvant Online for early breast cancer

    Valesca P. Retèl;Manuela A. Joore;Michael Knauer;Sabine C. Linn

  • Health-related quality of life in patients surviving non-small cell lung cancer

    Janneke P C Grutters;Manuela A Joore;Erwin M Wiegman;Johannes A Langendijk

  • Cost Evaluation of Dried Blood Spot Home Sampling as Compared to Conventional Sampling for Therapeutic Drug Monitoring in Children.

    Lisa C. Martial;Rob E. Aarnoutse;Michiel F. Schreuder;Stefanie S. Henriet

  • The cost-effectiveness of particle therapy in non-small cell lung cancer: exploring decision uncertainty and areas for future research.

    Janneke P.C. Grutters;Madelon Pijls-Johannesma;Dirk De Ruysscher;Andrea Peeters

  • Response shift in the measurement of quality of life in hearing impaired adults after hearing aid fitting.

    M.A. Joore;J. Potjewijd;A.A. Timmerman;L.J.C. Anteunis

  • The Impact of Differences in EQ-5D and SF-6D Utility Scores on the Acceptability of Cost–Utility Ratios: Results across Five Trial-Based Cost–Utility Studies

    Manuela A Joore;Danielle Brunenberg;Patricia Nelemans;Emiel Wouters

  • Acknowledging Patient Heterogeneity in Economic Evaluation A Systematic Literature Review

    Janneke P. C. Grutters;Mark Sculpher;Andrew H. Briggs;Johan L. Severens

  • Willingness to Accept versus Willingness to Pay in a Discrete Choice Experiment

    Janneke P.C. Grutters;Alfons G.H. Kessels;Carmen D. Dirksen;Debby van Helvoort-Postulart

  • Cost-effectiveness analysis of sacral neuromodulation and botulinum toxin A treatment for patients with idiopathic overactive bladder.

    Randall K. Leong;Stephan G. G. de Wachter;Manuela A. Joore;Philip E. V. A. Van Kerrebroeck

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Recently Published Articles